SEC Form 4 · accession 0001209191-16-138557
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nezam H. Afdhal
Officer — Chief Medical Officer
Period of report
Aug 24, 2016
Accepted (ET)
Aug 24, 2016 · 8:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2016 | P | 1,550 | $11.90 | A | 37,300 | D | |
| Common Stock | Aug 24, 2016 | P | 100 | $11.99 | A | 37,400 | D | |
| Common Stock | Aug 24, 2016 | P | 350 | $12.00 | A | 37,750 | D |
Table II — derivative securities
No Table II lines on this filing.